Application 090402
- Type
- ANDA
- Sponsor
- HERITAGE PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TACROLIMUS | TACROLIMUS | CAPSULE;ORAL | EQ 5MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090402-001 | TACROLIMUS | TACROLIMUS | EQ 5MG BASE | CAPSULE / ORAL | 2010-07-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A090402-001 | TACROLIMUS | EQ 5MG BASE | CAPSULE / ORAL | 2010-07-01 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A090402-001 | TACROLIMUS | EQ 5MG BASE | CAPSULE / ORAL | 2010-07-01 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A090402-001 | TACROLIMUS | EQ 5MG BASE | CAPSULE / ORAL | 2010-07-01 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A090402-001 | TACROLIMUS | EQ 5MG BASE | CAPSULE / ORAL | 2010-07-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tacrolimus | TACROLIMUS | Panacea Biotec Limited | bd9fea26-0236-d437-c7df-4b7636210875 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Stellon Biotech Inc. | 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Major Pharmaceuticals | 213f6047-f897-48a7-b78a-45d7124f2f16 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| tacrolimus | TACROLIMUS | A-S Medication Solutions | 3519febc-c9df-4559-b07a-92f8b0c7e770 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | tacrolimus TACROLIMUS |
| tacrolimus | TACROLIMUS | NORTHSTAR RX LLC | 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Major Pharmaceuticals | 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Glenmark Pharmaceuticals Inc., USA | c2d2e3a1-f346-4245-b445-6dd44e371180 | 2026-04-15 | Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Safecor Health LLC | 393cd10e-133c-4d6b-b024-270eb82edbb3 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Jubilant Cadista Pharmaceuticals Inc. | 651bd506-96b0-43e5-a4dd-db03bf9154c9 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1bf44a84-14fd-4f80-ad8a-99b1431d631f | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| tacrolimus | TACROLIMUS | Glenmark Pharmaceuticals Inc., USA | 4b310c6b-e035-4e44-9573-4001d58b2ad5 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | BPI Labs LLC | 3e8bc65e-8048-4073-8e45-570330603000 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Ajenat Pharmaceuticals LLC | ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Ascend Laboratories, LLC | 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Golden State Medical Supply, Inc. | 34ec4989-6933-4237-ae1e-50a0cb90a2fe | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Cardinal Health 107, LLC | e898ee90-faae-42a8-b652-be1c8730d856 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Nexus Pharmaceuticals, LLC | 9d502961-e9c0-4611-92bf-ce742a7b962c | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS | Amneal Pharmaceuticals NY LLC | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 2025-10-20 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
| Tacrolimus | TACROLIMUS OINTMENT 0.1% | Encube Ethicals, Inc. | 43b38551-6c5e-48a4-a453-9286f1c16b34 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | Tacrolimus |
| Tacrolimus | TACROLIMUS | Bryant Ranch Prepack | a2e55495-10cc-4f6e-b866-1e7d6e45888b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | Tacrolimus TACROLIMUS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.